MSLN and gastric cancer: The coexpression of sPH20-IgG2 (the secreted form of PH20) significantly enhanced the ability of anti-MSLN CAR-T cells to degrade HA in the treatment of gastric cancer with high MSLN expression; moreover, the infiltration efficiency of anti-MSLN-SP CAR-T cells in solid tumor tissues was improved.